NASDAQ:SLGLSol Gel Technologies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sol Gel Technologies Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $7.98 -0.07 (-0.87 %) (As of 06/5/2020 04:00 PM ET) Add Compare Share Today's Range$7.95Now: $7.98▼$8.0950-Day Range$7.45MA: $8.14▼$8.9552-Week Range$5.00Now: $7.98▼$21.00Volume10,400 shsAverage Volume58,708 shsMarket Capitalization$162.71 millionP/E RatioN/ADividend YieldN/ABeta1.6 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media Sol-Gel Technologies Ltd., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include TWIN and SIRS-T, which has completed Phase II clinical trials for the treatment of acne vulgaris; and VERED that has completed Phase II clinical trials for the treatment of papulopustular rosacea. It is also involved in the development of generic dermatological drug products. Sol-Gel Technologies Ltd. has collaboration with Perrigo; and Douglas Pharmaceuticals for the development and commercialization of a generic product candidate. The company was founded in 1997 and is headquartered in Ness Ziona, Israel.Read More Beat the Market (BTM) Rank™ 3.6 Analyst's Opinion Consensus RatingSol Gel Technologies has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $25.25, Sol Gel Technologies has a potential upside of 216.4% from its current price of $7.98.Amount of Analyst CoverageSol Gel Technologies has only been the subject of 1 research reports in the past 90 days. Previous Next 2.3 Community Rank Outperform VotesSol Gel Technologies has received 125 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSol Gel Technologies has received 144 “underperform” votes. (Add your “underperform” vote.)Community SentimentSol Gel Technologies has received 53.53% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Sol Gel Technologies and other stocks. Vote “Outperform” if you believe SLGL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SLGL will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSol Gel Technologies does not currently pay a dividend.Dividend GrowthSol Gel Technologies does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sol Gel Technologies insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 34.07% of the stock of Sol Gel Technologies is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Sol Gel Technologies are expected to grow in the coming year, from ($1.45) to ($1.39) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sol Gel Technologies is -6.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sol Gel Technologies is -6.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSol Gel Technologies has a P/B Ratio of 3.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.6Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.31 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SLGL Previous Symbol CUSIPN/A CIK1684693 Webwww.sol-gel.com Phone972-8931-3429Debt Debt-to-Equity Ratio0.02 Current Ratio9.51 Quick Ratio9.51Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$22.90 million Price / Sales7.11 Cash FlowN/A Price / Cash FlowN/A Book Value$2.57 per share Price / Book3.11Profitability EPS (Most Recent Fiscal Year)($1.26) Net Income$-24,610,000.00 Net Margins-129.88% Return on Equity-44.64% Return on Assets-38.59%Miscellaneous EmployeesN/A Outstanding Shares20,390,000Market Cap$162.71 million Next Earnings Date8/11/2020 (Estimated) OptionableNot Optionable NASDAQ:SLGL Rates by TradingView Receive SLGL News and Ratings via Email Sign-up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Sol Gel Technologies (NASDAQ:SLGL) Frequently Asked Questions How has Sol Gel Technologies' stock been impacted by COVID-19 (Coronavirus)? Sol Gel Technologies' stock was trading at $8.25 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SLGL stock has decreased by 3.3% and is now trading at $7.98. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Sol Gel Technologies? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sol Gel Technologies in the last year. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Sol Gel Technologies. When is Sol Gel Technologies' next earnings date? Sol Gel Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for Sol Gel Technologies. How were Sol Gel Technologies' earnings last quarter? Sol Gel Technologies Ltd (NASDAQ:SLGL) posted its earnings results on Thursday, May, 14th. The company reported ($0.33) EPS for the quarter, beating analysts' consensus estimates of ($0.38) by $0.05. The company had revenue of $3.47 million for the quarter, compared to analysts' expectations of $3.37 million. Sol Gel Technologies had a negative return on equity of 44.64% and a negative net margin of 129.88%. View Sol Gel Technologies' earnings history. What price target have analysts set for SLGL? 4 analysts have issued 12-month target prices for Sol Gel Technologies' shares. Their forecasts range from $21.00 to $33.00. On average, they expect Sol Gel Technologies' share price to reach $25.25 in the next twelve months. This suggests a possible upside of 216.4% from the stock's current price. View analysts' price targets for Sol Gel Technologies. Has Sol Gel Technologies been receiving favorable news coverage? News articles about SLGL stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Sol Gel Technologies earned a coverage optimism score of 0.7 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View the latest news aboutSol Gel Technologies. Are investors shorting Sol Gel Technologies? Sol Gel Technologies saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 53,400 shares, a decrease of 18.8% from the April 30th total of 65,800 shares. Based on an average daily volume of 65,100 shares, the days-to-cover ratio is currently 0.8 days. Approximately 0.7% of the shares of the stock are sold short. View Sol Gel Technologies' Current Options Chain. Who are some of Sol Gel Technologies' key competitors? Some companies that are related to Sol Gel Technologies include Sinovac Biotech (SVA), Assembly Biosciences (ASMB), Vanda Pharmaceuticals (VNDA), Stemline Therapeutics (STML), DiaMedica Therapeutics (DMCAF), Ardelyx (ARDX), Syndax Pharmaceuticals (SNDX), Dynavax Technologies (DVAX), Trillium Therapeutics (TRIL), Radius Health (RDUS), Frequency Therapeutics (FREQ), Aprea Therapeutics (APRE), Athersys (ATHX), Urogen Pharma (URGN) and Zafgen (ZFGN). View all competitors. What other stocks do shareholders of Sol Gel Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sol Gel Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Teva Pharmaceutical Industries (TEVA), Tesla (TSLA), Advanced Micro Devices (AMD), eHealth (EHTH), Gilead Sciences (GILD), Iovance Biotherapeutics (IOVA), Micron Technology (MU) and NeoPhotonics (NPTN). Who are Sol Gel Technologies' key executives? Sol Gel Technologies' management team includes the following people: Dr. Alon Seri-Levy, Co-Founder, CEO & Director (Age 58)Mr. Gilad Mamlok, Chief Financial Officer (Age 51)Mr. Itzik Yosef, VP of Operations (Age 43)Dr. Ofer Toledano, VP of R&D (Age 54)Dr. Ofra Levy-Hacham Ph.D., VP of Clinical & Regulatory Affairs (Age 53) When did Sol Gel Technologies IPO? (SLGL) raised $60 million in an IPO on Thursday, February 1st 2018. The company issued 5,000,000 shares at $11.00-$13.00 per share. Jefferies and BMO Capital Markets acted as the underwriters for the IPO and JMP Securities and Raymond James were co-managers. What is Sol Gel Technologies' stock symbol? Sol Gel Technologies trades on the NASDAQ under the ticker symbol "SLGL." Who are Sol Gel Technologies' major shareholders? Sol Gel Technologies' stock is owned by a number of retail and institutional investors. Top institutional investors include Phoenix Holdings Ltd. (13.25%), Ion Asset Management Ltd. (1.24%), Invesco Ltd. (0.39%), Raymond James Financial Services Advisors Inc. (0.22%), Raymond James & Associates (0.20%) and Morgan Stanley (0.09%). Which institutional investors are buying Sol Gel Technologies stock? SLGL stock was purchased by a variety of institutional investors in the last quarter, including Phoenix Holdings Ltd., Ion Asset Management Ltd., Invesco Ltd., Two Sigma Investments LP, Morgan Stanley, Raymond James Financial Services Advisors Inc., Raymond James & Associates, and Steward Partners Investment Advisory LLC. How do I buy shares of Sol Gel Technologies? Shares of SLGL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Sol Gel Technologies' stock price today? One share of SLGL stock can currently be purchased for approximately $7.98. How big of a company is Sol Gel Technologies? Sol Gel Technologies has a market capitalization of $162.71 million and generates $22.90 million in revenue each year. The company earns $-24,610,000.00 in net income (profit) each year or ($1.26) on an earnings per share basis. What is Sol Gel Technologies' official website? The official website for Sol Gel Technologies is www.sol-gel.com. How can I contact Sol Gel Technologies? Sol Gel Technologies' mailing address is 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK, NESS ZIONA L3, 7403648. The company can be reached via phone at 972-8931-3429 or via email at [email protected] This page was last updated on 6/5/2020 by MarketBeat.com Staff
